Muhammad Saleem

Muhammad Saleem

Auto-generated profile, based on publicly available information

Muhammad Saleem


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
QAQurrat- Ul- Ain
Qurrat- Ul- Ain
UAUzma Ashiq
Uzma Ashiq
RJRifat Ara Jamal
Rifat Ara Jamal
MSMuhammad Saleem
Muhammad Saleem
MMMohammad Mahroof-Tahir
Mohammad Mahroof-Tahir
This study focused on the synthesis and characterization of hydrazide ligands and their respective Pd(II) complexes and used high throughput screening to determine their α-glucosidase and carbonic anhydrase II enzyme inhibition activities. The physical, analytical (elemental analyses for C, H, N and Pd) and spectral (FT-IR, 1H NMR, 13C NMR, EI-mass) techniques utilized during characterization revealed the formation of square planar, neutral and 1:2 Pd(II)-hydrazide complexes with the general formula [PdL2Cl2]. In these Pd(II) complexes, the hydrazide ligands are monodentate; the terminal nitrogen is the donor atom. The uncoordinated hydrazide ligands were inactive against both α-glucosidase and carbonic anhydrase II enzymes; however, the respective Pd(II)-hydrazide complexes were approximately 300 times more potent α-glucosidase inhibitors than the standard compound, 1-deoxynojirimycin (DNJ). Some of the Pd(II) complexes also demonstrated potential carbonic anhydrase (CA) inhibition properties comparable to the standard compound, acetazolamide (ACZ)

1 July 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
AMAneela Maalik
Aneela Maalik
HRHina Rahim
Hina Rahim
MSMuhammad Saleem
Muhammad Saleem
NFNighat Fatima
Nighat Fatima
Abdur RaufAbdur Rauf
Abdur Rauf
AMAmara Mumtaz
Amara Mumtaz

1 November 2014 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
KKKhalid Mohammed Khan
Khalid Mohammed Khan
SSSalman Siddiqui
Salman Siddiqui
MSMuhammad Saleem
Muhammad Saleem
MTMuhammad Taha
Muhammad Taha
SSSyed Muhammad Saad
Syed Muhammad Saad
MCMuhammad Iqbal Choudhary
Muhammad Iqbal Choudhary

1 June 2017 in Bioorganic Chemistry
Verified
Journal Article
Closed access
SISarosh Iqbal
Sarosh Iqbal
MSMuhammad Saleem
Muhammad Saleem
MAM. Kamran Azim
M. Kamran Azim
MTMuhammad Taha
Muhammad Taha
USUzma Salar
Uzma Salar
MCMuhammad Iqbal Choudhary
Muhammad Iqbal Choudhary

5 April 2015 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
Abdur RaufAbdur Rauf
Abdur Rauf
MSMuhammad Saleem
Muhammad Saleem
GUGhias Uddin
Ghias Uddin
BSBina Shaheen Siddiqui
Bina Shaheen Siddiqui
Prof. Dr. Haroon KhanProf. Dr. Haroon Khan
Prof. Dr. Haroon Khan
Vincenzo De FeoVincenzo De Feo
Vincenzo De Feo
Pistacia integerrimais one of twenty species among the genusPistacia. Long horn-shaped galls that develop on this plant are harvested and used in Ayurveda and Indian traditional medicine to make “karkatshringi”, a herbal medicine used for the treatment of asthma and different disorders of respiratory tract. However, until now, the molecular mechanisms of action of “karkatshringi” and its chemical characterization are partially known. This study deals with the isolation and characterization of the active constituents from the methanolic extract ofP. integerrimagalls and it was also oriented to evaluatein vitroandin silicotheir potential enzymatic inhibitory activity against phosphodiesterase-1 (PDE1), a well-known enzyme involved in airway smooth muscle activity and airway inflammation. Our results showed that the methanolic extract ofP. integerrimagalls and some of its active constituents [naringenin (1) and 3,5,7,4′-tetrahydroxy-flavanone (2)] are ablein vitroto inhibit PDE1 activity (59.20 ± 4.95%, 75.90 ± 5.90%, and 65.25 ± 5.25%, resp.) and demonstratein silicoan interesting interaction with this enzymatic site. Taken together, our results add new knowledge of chemical constituents responsible for the biological activity ofP. integerrimaand contextually legitimate the use of this plant in folk medicine.

12 July 2019 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
VAVladimir Amirkhanov
Vladimir Amirkhanov
Abdur RaufAbdur Rauf
Abdur Rauf
THTaibi Ben Hadda
Taibi Ben Hadda
VOVladimir Ovchynnikov
Vladimir Ovchynnikov
VTViktor Trush
Viktor Trush
TFThoraya Farghaly
Thoraya Farghaly
Background: The function of Carbonic anhydrase is to facilitate the physiological process i.e. interconversion of CO2 to HCO3 - by hydration. Carbonic anhydrase enzyme plays a vital role in different physiological processes to regulate pH as well as regulate the inner environment of CO2 and secretion of electrolytes.Methods: Six representatives of amidophosphate derivatives (L1-L6) were synthesized and evaluated for their biological activities against carbonic anhydrase enzyme.Results: Out of six derivatives, L1 (IC50 = 12.5 ± 1.35 µM), and L2 (IC50 = 3.12 ± 0.45 µM) showed potent activity against BCA-II. While (L3, L4 and L5) showed weak inhibitory activity with IC50 values of 24.5 ± 2.25, 55.5± 1.60, and 75.5 ± 1.25 µM, respectively and were found to be weak inhibitors of carbonic anhydrase as compared to acetazolamide (IC50 =0.12± 0.03µM), used as standard inhibitor. A computational Petra/Osiris/Molinspiration/DFT (POM/DFT) based model has been expanded for the determination of physicochemical parameters governing the bioactivity amidophosphate derivatives (L1-L6) containing (O1 --- O2) pharmacophore site. The six compounds (L1-L6) analyzed here were previously experimentally and now virtually screened for their anti-carbonic anhydrase activity.: A computational Petra/Osiris/Molinspiration/DFT (POM/DFT) based model has been expanded for the determination of physicochemical parameters governing the bioactivity amidophosphate derivatives (L1-L6) containing (O1 --- O2) pharmacophore site. The six compounds (L1-L6) analyzed here were previously experimentally and now virtually screened for their anti-carbonic anhydrase activity.Conclusion: The highest anti-carbonic anhydrase activity was obtained for compound L2, which exhibited excellent bioactivity (% of inhibition = 95%), comparable to acetazolamide (% of inhibition = 89%). The compound L3 represents increased activity as compared to its analogues (L4-L6). The increase of bioactivity from L3 to L4-L6 could be attributed to the presence of a minimum of steric effect of substituents of P=O moiety which plays a decisive template part in the organization of anti-carbonic anhydrase (O1---O2) phramacophore site. Moreover, it is inexpensive, has little side effects and possible inclusions in selective anti-carbonic anhydrase agents design.